Iovance Biotherapeutics I... (IOVA)
NASDAQ: IOVA
· Real-Time Price · USD
3.35
-0.24 (-6.69%)
At close: May 01, 2025, 3:59 PM
Iovance Biotherapeutics Revenue
Iovance Biotherapeutics reported an annual revenue of $164.07M, reflecting a 13698.99% growth. For the quarter ending December 31, 2024, Iovance Biotherapeutics generated $73.69M in revenue.
Revenue (ttm)
$164.07M
Revenue Growth
13698.99%
Price / Sales Ratio
13.07
Revenue / Employee
$195.79K
Employees
838
Market Cap
1.1B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 164.07M | +13698.99% |
| Dec 31, 2023 | 1.19M | +Infinity% |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |